PURE Bioscience (PURE)
PURE Bioscience Revenue Growth: 281.0%
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
PURE Revenue Growth Rankings
| Overall | 98th percentile | 46 of 4363 |
| Sector | 98th percentile | 7 of 459 in Basic Materials |
| Industry | 92nd percentile | 1 of 14 in Chemicals - Major Diversified |
PURE Revenue Growth Range, Past 5 Years
| Minimum | -89.64% | Oct 2010 |
| Maximum | 11657% | Jul 2008 |
| Average | 745.0% |
About Revenue Growth
Revenue growth illustrates sales increases/decreases over time. It is used to measure how fast a business is expanding. More valuable than a snapshot of revenue, revenue growth helps investors identify trends in order to gauge revenue growth over time.
If a company generated $75 billion in revenue during 2008 and $100 billion in revenue during 2009, the company experienced roughly a ($100 billion/$75 billion)-1 = %33 increase in revenue.
Learn More
You may also be interested in these PURE related companies
PURE News
PURE Hard Surface Showcased at National Restaurant Association Show 2012
May 04, 8:00AM Business Wire
May 04, 8:00AM Business Wire
PURE Bioscience Announces AHI as Strategic Customer in Facilities Services Market
Apr 26, 8:00AM Business Wire
Apr 26, 8:00AM Business Wire
@Bud_Stocks $Pure yea, it could still go up but its not type of chart I'd buy at this stage
about 50 days ago by missyaubaby
about 50 days ago by missyaubaby
@Bud_Stocks $PURE too much for me my friend. I prefer stock over $1
about 50 days ago by micheleciani
about 50 days ago by micheleciani
PURE Bioscience Introduces the PURE Complete Cleaning, Sanitizing and Disinfecting System
Apr 11, 8:00AM Business Wire
Apr 11, 8:00AM Business Wire
Trading Radar for 03/16: China Sunergy (CSUN), ReneSola (SOL), US Energy (USEG), Lakes Entertainment (LACO) Report
Mar 15, 5:20PM Street Insider
Mar 15, 5:20PM Street Insider
PURE Bioscience to Report Second Quarter Fiscal 2012 Results on March 16
Mar 12, 3:26PM Business Wire
Mar 12, 3:26PM Business Wire
$PURE http://stks.co/28U9 For all you penny lovers, ascending triangle on 60 min.
about 124 days ago by katetrades
about 124 days ago by katetrades
PURE (PURE) Announces Purchase Agreement with Lincoln Park Capital for Up to $10M
Dec 15, 4:03PM Street Insider
Dec 15, 4:03PM Street Insider
$PURE Announces Purchase Agreements for up to $10 Million with Lincoln Park Capital Fund
about 168 days ago by Benzinga
about 168 days ago by Benzinga
PURE Bioscience to Report First Quarter Fiscal 2012 Results on December 15
Dec 09, 8:00AM Business Wire
Dec 09, 8:00AM Business Wire
James McClenahan to Spearhead Key Sales Channel Initiatives for PURE Bioscience
Dec 01, 8:00AM Business Wire
Dec 01, 8:00AM Business Wire
Stockholder Nominates Opposition Board Nominees for Election at Pure Bioscience Annual Meeting
Oct 31, 4:44PM PR Newswire
Oct 31, 4:44PM PR Newswire
PURE Bioscience to Report Fourth Quarter Fiscal 2011 Results on October 31
Oct 25, 8:00AM Business Wire
Oct 25, 8:00AM Business Wire
the average volume is scary, though! RT @Modhumoti @blackbetty planing to buy $PURE above one dollar
about 257 days ago by blackbetty
about 257 days ago by blackbetty
Looks interesting, in fact if can get over 1.21 resistance, might be good to 1.50 RT @Modhumoti @blackbetty planing to buy $PURE above..
about 257 days ago by blackbetty
about 257 days ago by blackbetty
PURE Bioscience engages Force Fuels for preliminary testing, product research
Sep 14, 8:02AM FlyOnTheWall
Sep 14, 8:02AM FlyOnTheWall
Outperform Rating For BASF According To Senior Analyst; Petrochemical Growth Continues To Be Strong Due To Recent Supply/Demand Balances
Aug 12, 1:15PM Wall Street Transcript
Aug 12, 1:15PM Wall Street Transcript
PURE Bioscience Presents PURE Hard Surface at American Correctional Association’s Annual Congress
Aug 08, 7:00AM Business Wire
Aug 08, 7:00AM Business Wire
$PURE http://chart.ly/niel26g Right sector but low price on watch list over line but speculative with 9% volume
about 370 days ago by StockTiger
about 370 days ago by StockTiger
$PURE http://chart.ly/qth93ky The sector is right at least - a weak chart but dollar stock could be at least a trade over $1.15
about 371 days ago by StockTiger
about 371 days ago by StockTiger
Market Wrap Video + Additions to Break Out Watch List http://st2.biz/270511 including $PRXL $RES $CODE $WPI $DG $CTAS $PURE $TKLC
about 371 days ago by StockTiger
about 371 days ago by StockTiger
$PURE http://chart.ly/4vaty6k Weekly chart, broke descending T/L, on high volume, if you like lower price stocks.
about 378 days ago by Phila_trader
about 378 days ago by Phila_trader
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| PURE | 0.34 | +0.01 | +3.03% | 15.74M |
| PULS | 1.93 | -0.04 | -2.03% | 82.96M |
| PULB | 7.25 | +0.00 | +0.00% | 81.85M |
| PUK | 20.99 | +0.23 | +1.11% | 26.45B |
| PTX | 6.59 | -0.47 | -6.66% | 181.72M |
| PTSX | 0.57 | +0.00 | +0.00% | 5.991M |
| PTRY | 12.89 | -0.03 | -0.23% | 300.52M |
| PTR | 125.99 | +0.34 | +0.27% | 229.94B |
| PRU | 46.45 | -0.20 | -0.43% | 21.92B |
| PRTS | 4.11 | +0.10 | +2.49% | 122.91M |
